Hyperleptinemia as a risk factor for high blood pressure in the elderly

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 2, 2006, Pages 170-175

  Mendoza Núñez, Víctor Manuel ^a   Correa Muñoz, Elsa ^a   Garfias Cruz, Elsa A ^a   Sánchez Rodriguez, Martha A ^a   Galván Duarte, Rosa Elba ^b   Retana Ugalde, Raquel ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERLEPTINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; AGED; BLOOD PRESSURE; BODY CONSTITUTION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; LEPTIN; MALE; MEXICO; ODDS RATIO; RISK FACTORS;

EID: 32544440920     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. Part I: aging arteries: a "set up" for vascular disease. Circulation. 2003;107:139-146.
2. Cheitlin MD. Cardiovascular physiology: changes with aging. Am J Geriatr Cardiol. 2003;12:9-13.
3. Casiglia E, Mazza A, Tikhonoff V, Scarpa R, Guglielmi F, Pessina AC. Arterial hypertension and mortality in the elderly. Am J Hypertens. 2002;15:958-966.
4. Plante GE. Impact of aging on the body's vascular system. Metabolism. 2003;52:31-35.
5. Khattar RS, Swales JD, Dore C, Senior R, Lahiri A. Effect of ageing on the prognostic significance of ambulatory systolic, diastolic, and pulse pressure in essential hypertension. Circulation. 2001;104:783-789.
6. Henriksen JH, Holst JJ, Moller S, Andersen UB, Bendtsen F, Jensen C. Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin. Clin Sci. 2000;99:527-534.
7. Canatan H, Bakan I, Akbulut M, Baydas C, Halifeoglu I, Gursu MF. Comparative analysis of plasma leptin levels in both genders of patients with essential hypertension and healthy subjects. Endocr Res. 2004;30:95-105.
8. Sánchez-Rodríguez MA, García-Sánchez A, Retana-Ugalde R, Mendoza-Núñez VM. Serum leptin levels and blood pressure in the overweight elderly. Arch Med Res. 2000;31:380-385.
9. Adamczac M, Kokot F, Wiecek AW. Relationship between plasma renin profile and leptinaemia in patients with essential hypertension. J Hum Hypertens. 2000;14:503-509.
10. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-432.
11. Zhang F, Babinski MB, Beals JM, Bringgs SL, Churgay LM, Clawson DK. Crystal structure of the obese protein leptin-E100. Nature. 1997;387:206-210.
12. Shimokawa I, Higami Y. Leptin signaling and ageing: insight from caloric restriction. Mech Ageing Dev. 2001;122:1511-1519.
13. Yeh S, Schuster MW. Geriatric cachexia: the role of cytokines. Am J Clin Nutr. 1999;70:183-197.
14. Gualillo O, Eiras S, Lago F, Dieguez C, Casanueva FF. Evaluated serum leptin concentrations induced by experimental acute inflammation. Life Sci. 2000;67:2433-2441.
15. Beltowski J, Wójcicka G, Marciniak A, Jamroz A. Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Life Sci. 2004;74:2987-3000.
16. Ren J. Leptin and hyperleptinemia: from friend to foe for cardiovascular function. J Endocrinol. 2004;181:1-10.
17. Moller N, O'Brien P, Nair KS. Disruption of the relationship between fat content and leptin levels with aging in humans. J Clin Metab. 1998;83:931-934.
18. Peralta S, Carrascosa JM, Gallardo N, Ros M, Arribas C. Ageing increases SOCS-3 expression in rat hypothalamus: effects of food restriction. Biochem Biophys Res Comm. 2002;296:425-428.
19. Bjorbaek C, El-Haschimi K, Frantz JD, Flier JS. The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem. 1999;274:30059-30065.
20. Gabriely I, Ma XH, Yang XM, Rossetti L, Barzilai N. Leptin resistance during aging is independent of fat mass. Diabetes. 2002;51:1016-1021.
21. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem. 1996;42:942-945.
22. Mendoza-Núñez VM, García-Sánchez A, Sánchez-Rodríguez MA, Galván-Duarte R, Fonseca-Yerena E. Overweight, waist circumference, age, gender, and insulin resistance as risk factors for hyperleptinemia. Obes Res. 2002;10:253-259.
23. Kuzuya H, Blix P, Horwitz D, Steiner D, Rubeinstein A. Determination of free and total insulin and C-peptide in insulin-treated diabetes. Diabetes. 1977;26:22-29.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
25. Unger RH. The physiology of cellular liporegulation. Ann Rev Physiol. 2003;65:333-347.
26. Baile CA, Della-Fera A, Martín RJ. Regulation of metabolism and body fat mass by leptin. Annu Rev Nutr. 2000;20:105-127.
27. Ma XH, Muzumdar R, Yang XM, Gabriely I, Berger R, Barzilai N. Aging is associated with resistance to effects of leptin on fat distribution and insulin action. J Gerontol A Biol Sci Med Sci. 2002;57:B225-B231.
28. Ceddia RB, Koistinen HA, Zierath JR, Sweeney G. Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J. 2002;16:1163-1176.
29. Moghadasian MH. Experimental atherosclerosis. A historical overview. Life Sci. 2002;70:855-865.
30. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
31. Haynes WG. Interaction between leptin and sympathetic nervous system in hypertension. Curr Hypertens Rep. 2000;2:311-318.
32. Mendoza-Núñez VM, Sánchez-Rodríguez MA, Galván-Duarte RE, Retana-Ugalde R. Hyperleptinemia and oxidative stress in elderly with arterial hypertension. TIP Rev Esp Cienc Quim Biol. 2003;6:81-86.
33. Nishina M, Kikuchi T, Yamasaki H, Kameda K, Hiura M, Uchiyama M. Relationship among systolic blood pressure, serum insulin and leptin, and visceral fat accumulation in obese children. Hypertens Res. 2003;26:281-288.
34. Guagnano MT, Manigrasso MR, Ballone E, et al. Association between serum leptin levels and 24-hour blood pressure in obese women. Obes Res. 2003;11:549-555.
35. Barba G, Russo O, Siani A, et al. Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Obes Res. 2003;11:160-166.
36. Zamboni M, Zoico E, Fantin F, et al. Relation between leptin and the metabolic syndrome in elderly women. J Gerontol A Biol Sci Med Sci. 2004;59:396-400.
37. Schutte R, Huisman HW, Schutte AE, Malan NT. Leptin is independently associated with systolic blood pressure, pulse pressure and arterial compliance in hypertensive African women with increased adiposity: the POWIRS study. J Hum Hypertens. 2005;19:535-541.
38. Correia MLG, Haynes WG, Rahmouni K, Morgan DA, Sivitz WI, Mark AL. The concept of selective leptin resistance. Evidence from agouti yellow obese mice. Diabetes. 2002;51:439-442.
39. Shintani M, Ikegami H, Fujisawa T, et al. Leptin genepolymorphism is associated with hypertension independent of obesity. J Clin Endocrinol Metab. 2002;87:2909-2912.
40. Wang ZM, Pan WT, Lee Y, Kakuma T, Zhou YT, Unger RH. The role of leptin resistance in the lipid abnormalities of aging. FASEB J. 2001;15:108-114.
41. Tamaya-Mori N, Uemura K, Iguchi A. Aging accelerates dietary lard-induced increase in blood pressure in rats. Exp Gerontol. 2003;38:905-910.
42. Mallamaci F, Cuzzola F, Tripepi C, et al. Gender-dependent differences in plasma leptin in essential hypertension. Am J Hypertens. 2000;13:914-920.
43. Takizawa H, Ura N, Saitoh S, et al. Gender difference in the relationships among hyperleptinemia, hyperinsulinemia, and hypertension. Clin Exp Hypertens. 2001;23:357-368.
44. Nawrot T, Hond ED, Thijs L, Staessen JA. Isolated systolic hypertension and the risk of vascular disease. Curr Hypertens Rep. 2003;5:372-379.
45. Quehenberger P, Exner M, Sunder-Plassmann R, et al. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res. 2002;90:711-720.
46. Iglarz M, Schiffrin EL. Role of endothelin-1 in hypertension. Curr Hypertens Rep. 2003;5:144-148.
47. da Silva AA, Kuo JJ, Tallam LS, Hall JE. Role of endothelin-1 in blood pressure regulation in a rat model of visceral obesity and hypertension. Hypertension. 2004;43:383-387.
48. Bouloumié A, Drexler HCA, Lafontan M, Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res. 1998;83:1059-1066.
49. Park H-Y, Kwon HM, Lim HJ, et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med. 2001;33:95-102.
50. Bouloumié A, Marumo T, Lafontan M, Busse R. Leptin induces oxidative stress in human endothelial cells. FASEB J. 1999;13:1231-1238.
51. Balasubramaniyan V, Sailaja JK, Nalini N. Role of leptin on alcohol-induced oxidative stress in Swiss mice. Pharmacol Res. 2003;47:211-216.
52. Eikelis N, Schlaich M, Aggarwal A, Kaye D, Esler M. Interactions between leptin and the human sympathetic nervous system. Hypertension. 2003;41:1072-1079.
53. Barzilai N, Grupta G. Interaction between aging and syndrome X: new insights on the pathophysiology of fat distribution. Ann NY Acad Sci. 1999;892:58-72.
54. Creutzberg EC, Wouters EF, Vanderhaven-Augustin IM, Dentener MA, Schols AM. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;162:1239-1245.
55. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol. 2000;68:437-446.
56. Olsson T, Nasman B, Rasmuson S, Ahren B. Dual relation between leptin and cortisol in humans is disturbed in Alzheimer's disease. Biol Psychiatry. 1998;44:374-376.